Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Recruiting 2Completed 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4Other 1

Conditions

Squamous Cell Carcinoma of Head and Neck 80Head and Neck Neoplasms 72Nasopharyngeal Carcinoma 61Prostatic Neoplasms 51Oropharyngeal Neoplasms 30Carcinoma, Non-Small-Cell Lung 27Rectal Neoplasms 23Carcinoma, Squamous Cell 23Breast Neoplasms 23Glioblastoma 22Uterine Cervical Neoplasms 18Carcinoma 18Neoplasm Metastasis 16Brain Neoplasms 16Nasopharyngeal Neoplasms 15Pancreatic Neoplasms 14Lung Neoplasms 13Gliosarcoma 13Glioma 13Esophageal Neoplasms 13Radiation Injuries 12Mouth Neoplasms 12Laryngeal Neoplasms 12Esophageal Squamous Cell Carcinoma 12Astrocytoma 12Tongue Neoplasms 11Hypopharyngeal Neoplasms 11Sarcoma 10Neoplasms 10Salivary Gland Neoplasms 8

Interventions

Low-Level Light Therapy 14Fibroblast Growth Factor 7 10Cisplatin 6Standard of Care 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Propolis 4Mouthwashes 4Cryotherapy 4Water 3Sodium Bicarbonate 3Saline Solution 3Radiotherapy 3Laser Therapy 3Injections 3Drug Therapy 3Control Groups 3Benzydamine 3golotimod 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Vitamin E 2Vitamin B 12 2Sodium Chloride 2Saliva, Artificial 2RRx-001 2Practice Guidelines as Topic 2Lidocaine 2Honey 2Glutamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Stomatitis × Radiotherapy, Intensity-Modulated × Clear all
NCT06532279 2026-05-04

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NRG Oncology

Phase 2 Recruiting
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
38 enrolled 10 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
223 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡